Have you been diagnosed with autism and/or depression?
The McPartland lab offers a study that will evaluate the effects of Transcranial Magnetic Stimulation (TMS), a type of noninvasive brain stimulation for potentially treating depression in autistic individuals. Depression is common in autism so there is a need to better understand why autistic individuals have higher rates of depression than neurotypical individuals. In addition, many autistic individuals with depression may not respond to standard antidepressant medications. In our study, we conduct clinical assessments, then EEG and eye tracking experiments before and after TMS.
We are recruiting adults with and without autism or depression between the ages of 18-40. Study participants will be compensated up to $250.
To learn more about the study or to participate, please call us at 203-737-3439 or email our team at autism@yale.edu.
Sponsored by American Academy of Child and Adolescent Psychiatry, and the Alan B. Slifka Foundation; HIC#2000035486
Has a doctor told you that you may have Tardive Dyskinesia (TD)?
If you are between the ages of 26 and 84, have been told by a doctor that you may have Tardive Dyskinesia (TD), and you have never been treated for this condition you may be eligible to participate in a free and confidential research study investigating psychological adjustment to TD.
If you enroll, you will meet in two separate meetings with a neurologist who will determine if you have TD and with a psychiatrist who will ask you several questions about your psychological adjustment to this condition.
If you complete the participation in this study, you will be compensated with $200.00 for your participation in both meetings.
To learn more or see if you are eligible please email helpusdiscover@yale.edu or call 1-877-978-8343.
Sponsored by Neurocrine Biosciences, Inc.; HIC#2000031135
Have you been diagnosed with Depression?
Psilocybin for Major Depressive Disorder (the uAspire Study)
Compensation of up to $1400 is provided.
For more information and to see if you are eligible to participate, email enact@yale.edu. Click here for more information about the trial.
Sponsored by Usona Institute; HIC#2000037179
Have you experienced a life-threatening event?
If you are between the ages of 18-60 and have experienced a traumatic or life-threatening event, you may be eligible to participate in a research study examining brain activity in individuals with PTSD. Study visits involve a psychological screening over Zoom to determine eligibility, a 90-minute fMRI scan, and a 90-minute MEG scan. This is not a treatment study, but your participation will play an important role in helping to advance treatment.
Participants will receive $50 for the psychological screen, $100 for the fMRI, and $150 for the MEG, as well as travel reimbursement.
If you are interested in learning more, please email us at ptsd.stress.lab@yale.edu or call/text (203) 936-9322.
Sponsored by Yale University School of Medicine, HIC# 2000025892
Do you have Post-Traumatic Stress Disorder (PTSD) and are interested in a new, rapid 7 day treatment?
Combining Neurobiology and New Learning (Ketamine/midazolam combined with psychotherapy) for a Potential Rapid Treatment for PTSD
We are currently recruiting participants with PTSD who are 21 to 70 years old for a study that involves a week long treatment for those with PTSD.
Compensation up to $900.
If you are interested in learning more, please email us at ptsd.stress.lab@yale.edu or call/text (203) 936-9322.
Sponsored by National Institutes of Health (NIH); National Center for PTSD (NCPTSD); Yale University School of Medicine; HIC# 1509016530
Young adults (18-19 years) with higher weight seeking treatment for bulimia nervosa
This study will test the feasibility and acceptability of two treatments for individuals with higher weight seeking treatment for bulimia nervosa. Bulimia nervosa is when individuals binge eat (overeat while feeling like they lost control) and purge (do something extreme or unhealthy to lose weight or prevent weight gain). Bulimia nervosa happens across different ages and body sizes.
This study is focusing on young adults (ages 18 or 19) who have a larger body size (overweight or obesity, or recent substantial weight loss). Individuals will receive treatment that is 4 months of 45-minute sessions, weekly. Treatment will occur over telehealth (e.g., zoom), and the whole study is online.
To learn more please contact Yale Teen Power at 203-785-7210 or email: teenpower@yale.edu.
Sponsored by National Eating Disorders Association; Yale University School of Medicine; HIC# 2000033150
Do you have trichotillomania?
Efficacy of Valbenazine for the Treatment of Trichotillomania in Adults
If you are an adult with trichotillomania, you may be eligible to participate in a research study run by the Yale School of Medicine. This study will examine the efficacy of Valbenazine for the treatment of trichotillomania. Valbenazine is a dopamine-depleting agent that is currently FDA-approved for tardive dyskinesia and has a relatively safe side-effect profile in initial trials.
While enrolled in the trial, you will receive regular psychiatric and medical assessments of symptoms at no cost. Additionally, you will receive a stipend of up to $590 over the course of 26 weeks for your participation.
If you are interested in the trial or wish to learn more, please do not hesitate to contact us by phone at 203-737-4809 or email at blochresearch@yale.edu if you have any questions about the trial.
Sponsored by Neurocrine Biosciences, Inc.; HIC# 2000034993
Are you experiencing suicidal thoughts but NOT planning to act on them? Have you tried antidepressants before without much success?
Help us understand the effects of the rapid antidepressant ketamine on the brain and earn up to $435 for your time.
For more information and to see if you are eligible to participate, contact 203-508-7787 or email nempro.lab@yale.edu.
Sponsored by American Foundation for Suicide Prevention, HIC# 2000033608
Are you Depressed?
Have you tried antidepressants before without much success? Help us understand the effects of the rapid antidepressant ketamine on the brain and earn up to $720 for your time.
For more information and to see if you are eligible to participate, contact 203-508-7787 or email nempro.lab@yale.edu.
Sponsored by National Institutes of Mental Health, HIC# 2000021345
Concerned about eating or overeating?
If you are between 21 and 50 years old with binge-eating disorder, you may be eligible for a brain-imaging study. Study visits involve in-person screening visits to determine eligibility, a 30-minute MRI scan, and a 90-minute PET scan. This is not a treatment study.
Compensation up to $500.
If you are interested in participating, or if you have any questions, please contact our study coordinators, Adam Stryjewski (adam.stryjewski@yale.edu; 203-535-4424) or Marcella Mignosa (marcella.mignosa@yale.edu; 203-903-7795) and mention “binge-eating study.”
Sponsored by National Institute of Mental Health (NIMH); HIC#2000034271
Are you aged 12-30 and noticing a recent change in your thinking, behavior, or experiences?
Pro-Net Study
If you're between the ages of 12 and 30 and have recently experienced changes in your thinking, behavior, or experiences, you may qualify for this study. These changes include confusion between reality and imagination, feeling a lack of control over your thoughts or ideas, being suspicious or paranoid, experiencing unreal sensations like hearing sounds or seeing things that aren't there, and having difficulty communicating clearly.
Participants in this study will undergo an initial screening visit, 2 MRI scans, and 2 sets of blood work. Additionally, they will be asked questions about their experiences and emotional well-being.
Total compensation of up to $1000 is provided.
To inquire further or determine eligibility for participation, please contact us at 203-200-8997 or email pronetstudy@yale.edu.
Sponsored by National Institute of Mental Health (NIMH); HIC# 2000029159
Have you experienced a traumatic event?
If you are between the ages of 18 to 45, you can help in advancing research about trauma and its impacts. Compensation will be provided.
If you’re interested, please fill out our screening questionnaire to see if you are eligible: https://redcap.research.yale.edu/surveys/?s=4F4TNRX473PH97NX
Sponsored by the National Institute of Mental Health and the Yale University School of Medicine; HIC# 2000026215
Have you been diagnosed with a psychotic-spectrum disorder? Do you experience auditory hallucinations?
If you are between the ages of 18 and 65, are right-handed, and speak English, you could help advance psychiatric research by participating in our brain imaging study. Auditory hallucinations are among the most distressing aspects of psychotic illness, and between 10 and 30% of people with hallucinations do not respond to antipsychotic medications. Help us take the first step toward individualized treatment approaches to hallucinations.
Compensation up to $400 for your participation.
For more information, and see if you are eligible to participate, please contact us: Text or call: 203-441-7213 email: powerslab3@gmail.com.
Sponsored by Burroughs Wellcome Fund; National Institute of Mental Health (NIMH); Yale University School of Medicine;HIC# 2000024774
Do you act out your dreams?
Neuro-immune Interactome in Parkinson's Disease
If you are over 40 years of age and do act out your dreams by kicking or punching out along with talking and/or yelling, you may have REM behavior disorder. REM Sleep Behavior Disturbance (RBD) is a sleep problem which may (or may not) be an early sign of Parkinson’s Disease (PD) or other neurological problems. The purpose of this research study is to determine whether or not RBD is associated with an immune process initiated in the gut, and to identify the earliest immunological changes in people at risk for developing PD. Your participation will require one or two phone or online interviews, and two to three in-person visits to research facilities at Yale New Haven Hospital, then yearly visits thereafter.
Compensation up to $500.
To learn more or see if you are eligible to participate, email Samantha Esposito at samantha.esposito@yale.edu or call 203-785-4261.
Sponsored by Michael J. Fox Foundation and Yale University School of Medicine; HIC#: 2000029032
Do you have Parkinson’s disease and symptoms of depression?
Depression can have a real impact on quality of life. But right now treatments for depression in PD are inadequate. We believe that the drug ketamine could reduce depression and possibly target other symptoms of PD.
The trial will involve receiving either ketamine or placebo twice per week for 3 weeks. You will also have the option to take part in brain imaging before and after the treatment.
You will be reimbursed up to $2000 for your time.
Contact us to find out more. Call or Text: (475) 287-9521 E-mail: ketaminepd@yale.edu. Click here for more information on this trial.
Sponsored by National Institute of Neurological Disorders and Stroke (NINDS); HIC #2000033352
Are you a first-time expectant mother or father? Help us learn about changes across the transition to parenthood.
If you are currently expecting a child for the first time, you and/or your partner may be eligible to participate in a research study focused on understanding more about emotions, the brain, and behavior in new parents before and after the baby is born.
This study involves: 1) a brief online study visit during the third trimester of pregnancy, and 2) one in- person lab visit with you and your infant around 2-4 months after delivery. You would complete surveys, tasks, and non-invasive measures of brain activity as part of the study.
Compensation for this study is $100 ($20 for pregnancy visit, $80 for after-delivery visit) in the form of gift cards. If your partner is also participating, you would each be separately compensated $100. Compensation for parking/travel is also available.
If you are interested in participating in the Emotions, Brain, and Behavior (EBB) Study for new parents, please email us at thebabl@yale.edu or call/text 475-500-5828.
Sponsored by American Psychological Foundation; HIC# 2000033554